Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Am J Geriatr Psychiatry ; 31(2): 112-123, 2023 02.
Article in English | MEDLINE | ID: mdl-36274019

ABSTRACT

OBJECTIVE: Small Vessel Disease (SVD) is known to be associated with higher AD risk, but its relationship to amyloidosis in the progression of AD is unclear. In this cross-sectional study of cognitively normal older adults, we explored the interactive effects of SVD and amyloid-beta (Aß) pathology on hippocampal functional connectivity during an associative encoding task and on hippocampal volume. METHODS: This study included 61 cognitively normal older adults (age range: 65-93 years, age mean ± standard deviation: 75.8 ± 6.4, 41 [67.2%] female). PiB PET, T2-weighted FLAIR, T1-weighted and face-name fMRI images were acquired on each participant to evaluate brain Aß, white matter hyperintensities (WMH+/- status), gray matter density, and hippocampal functional connectivity. RESULTS: We found that, in WMH (+) older adults greater Aß burden was associated with greater hippocampal local connectivity (i.e., hippocampal-parahippocampal connectivity) and lower gray matter density in medial temporal lobe (MTL), whereas in WMH (-) older adults greater Aß burden was associated with greater hippocampal distal connectivity (i.e., hippocampal-prefrontal connectivity) and no changes in MTL gray matter density. Moreover, greater hippocampal local connectivity was associated with MTL atrophy. CONCLUSION: These observations support a hippocampal excitotoxicity model linking SVD to neurodegeneration in preclinical AD. This may explain how SVD may accelerate the progression from Aß positivity to neurodegeneration, and subsequent AD.


Subject(s)
Alzheimer Disease , Hippocampus , Humans , Female , Aged , Aged, 80 and over , Male , Cross-Sectional Studies , Hippocampus/diagnostic imaging , Hippocampus/pathology , Brain/metabolism , Amyloid beta-Peptides/metabolism , Magnetic Resonance Imaging , Atrophy/pathology , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/pathology
2.
Nat Commun ; 12(1): 3416, 2021 06 07.
Article in English | MEDLINE | ID: mdl-34099706

ABSTRACT

APOE and Trem2 are major genetic risk factors for Alzheimer's disease (AD), but how they affect microglia response to Aß remains unclear. Here we report an APOE isoform-specific phospholipid signature with correlation between human APOEε3/3 and APOEε4/4 AD brain and lipoproteins from astrocyte conditioned media of APOE3 and APOE4 mice. Using preclinical AD mouse models, we show that APOE3 lipoproteins, unlike APOE4, induce faster microglial migration towards injected Aß, facilitate Aß uptake, and ameliorate Aß effects on cognition. Bulk and single-cell RNA-seq demonstrate that, compared to APOE4, cortical infusion of APOE3 lipoproteins upregulates a higher proportion of genes linked to an activated microglia response, and this trend is augmented by TREM2 deficiency. In vitro, lack of TREM2 decreases Aß uptake by APOE4-treated microglia only, suggesting TREM2-APOE interaction. Our study elucidates phenotypic and transcriptional differences in microglial response to Aß mediated by APOE3 or APOE4 lipoproteins in preclinical models of AD.


Subject(s)
Alzheimer Disease/pathology , Apolipoprotein E3/metabolism , Apolipoprotein E4/metabolism , Brain/pathology , Microglia/pathology , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , Apolipoprotein E3/administration & dosage , Apolipoprotein E3/genetics , Apolipoprotein E4/administration & dosage , Apolipoprotein E4/genetics , Brain/cytology , Disease Models, Animal , Female , Humans , Male , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice , Mice, Transgenic , Mutation , Phospholipids/metabolism , Presenilin-1/genetics , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA-Seq , Receptors, Immunologic/genetics , Receptors, Immunologic/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL